A study published in October, 2011 in the European Respiratory Journal compared indacaterol with tiotropium over the study period of 12 weeks. The study found no statistical difference between the effects of the two drugs on FEV<sub>1</sub>. Indacaterol yielded greater improvements in transition dyspnoea index (TDI) total score and St. George’s Respiratory Questionnaire (SGRQ) total score.<ref name=Buhl2011>{{cite journal |author=R. Buhl |title=Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD |journal=[[European Respiratory Journal]] |volume=38 |issue=4 |pages=797–803  |date=October 2011 |pmid=21622587 |doi=10.1183/09031936.00191810|author-separator= |author2= L.J. Dunn |author3= C. Disdier  |displayauthors=etal  }}</ref>
